Slingshot Insights | Sls Overview

SLS Overview

Upcoming Projects (SLS)

Don’t see a project related to the company you care about? Create your own!

Expired Projects (SLS)

Exploring Advancements in AML Treatment: Insights into SELLAS Life Sciences Group, Inc.'s Phase 2a Trial of SLS009
Ticker: SLS
Execute By: Jul 31, 2024

Upcoming & Overdue Catalysts (SLS)

Don’t see a catalyst related to the company you care about? Create your own!

Occurred Catalysts (SLS)

SELLAS Life Sciences (SLS) Provides FDA Type C Review Update for Nelipepimut-S (NPS) for Triple Negative Breast Cancer (TNBC); Phase 3 design and plan now finalized
Ticker: SLS
Occurred on: Feb 14, 2020
Phase 3 final endpoint of NeuVax (E75) for low-to-intermediate HER2+ breast cancer is expected to be reached in 2018 - Terminated
Tickers: SLS, GALE
Occurred on: Jun 01, 2018

Strategic Initiatives (SLS)

Don’t see a strategic initiative related to the company you care about? Create your own!